Related Experiment Video
Updated: Jan 13, 2026

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
Biological classification of memory clinic patients
Sophie E Mastenbroek1,2,3, Lyduine E Collij1,2,3, Toomas Erik Anijärv1
1Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Faculty of Medicine, Lund University, Lund 222 42, Sweden.
A new biomarker framework categorizes memory clinic patients into five profiles: Alzheimer's disease, α-Synuclein disease, vascular disease, mixed, and a novel group (NOVAS). This approach aids diagnosis and predicts disease progression for neurodegenerative conditions.
Area of Science:
- Neuroscience
- Biomarker Discovery
- Clinical Neurology
Background:
- Traditional neurodegenerative disease definitions rely on clinical symptoms.
- Biomarker development enables in vivo biological definitions.
- Characterizing memory clinic populations requires multi-dimensional biomarker data.
Purpose of the Study:
- To develop a data-driven biological framework for categorizing memory clinic patients.
- To identify distinct clinico-pathological entities using multimodal biomarkers.
- To compare clinical symptoms, progression, and brain changes across identified profiles.
Main Methods:
- Studied 1,677 individuals (SCD, MCI, dementia, controls) from the BioFINDER-2 cohort.
- Applied the Subtype and Stage Inference (SuStaIn) model to biomarkers: Aβ, tau PET, α-synuclein SAA, WMHs, and cortical thickness.
- Analyzed clinical symptoms, disease progression, and brain changes (atrophy, functional connectivity) in symptomatic individuals.
Main Results:
- Identified five biomarker clusters: Alzheimer's disease (AD), α-Synuclein disease (αSyn), Vascular disease, Mixed AD/Vascular, and NOVAS.
- AD profile showed global cognitive decline; αSyn profile exhibited visuospatial/executive dysfunction and motor impairment.
- Vascular and Mixed profiles indicated language/motor impairments and subcortical atrophy; NOVAS showed hippocampal/amygdala atrophy, potentially representing other pathologies.
Conclusions:
- Multimodal biomarker classification provides valuable diagnostic and prognostic insights for neurodegenerative diseases.
- The identified profiles correlate with distinct clinical trajectories and underlying pathologies.
- This framework has potential implications for optimizing clinical trial design and patient stratification.
Related Concept Videos
Higher Mental Functions of Brain: Learning and Memory
Explicit Memories
Episodic memory contains information about personally experienced events and is reported as a story. An example of episodic memory is recalling a birthday celebration. This type of memory includes the what, where, and when of an event, as...
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Microbial Classification System
System of Memory
Amnesia
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...

